Literature DB >> 19587453

Epidermolysis bullosa simplex: a paradigm for disorders of tissue fragility.

Pierre A Coulombe1, Michelle L Kerns, Elaine Fuchs.   

Abstract

Epidermolysis bullosa (EB) simplex is a rare genetic condition typified by superficial bullous lesions that result from frictional trauma to the skin. Most cases are due to dominantly acting mutations in either keratin 14 (K14) or K5, the type I and II intermediate filament (IF) proteins tasked with forming a pancytoplasmic network of 10-nm filaments in basal keratinocytes of the epidermis and in other stratified epithelia. Defects in K5/K14 filament network architecture cause basal keratinocytes to become fragile and account for their trauma-induced rupture. Here we review how laboratory investigations centered on keratin biology have deepened our understanding of the etiology and pathophysiology of EB simplex and revealed novel avenues for its therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19587453      PMCID: PMC2701872          DOI: 10.1172/JCI38177

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  118 in total

1.  Epidermolysis bullosa resembling juvenile dermatitis herpetiformis.

Authors:  G B DOWLING; R H MEARA
Journal:  Br J Dermatol       Date:  1954-04       Impact factor: 9.302

Review 2.  Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds.

Authors:  Pierre A Coulombe; Pauline Wong
Journal:  Nat Cell Biol       Date:  2004-08       Impact factor: 28.824

Review 3.  Intermediate filament proteins and their associated diseases.

Authors:  M Bishr Omary; Pierre A Coulombe; W H Irwin McLean
Journal:  N Engl J Med       Date:  2004-11-11       Impact factor: 91.245

4.  Clinical heterogeneity of 1649delG mutation in the tail domain of keratin 5: a Japanese family with epidermolysis bullosa simplex with mottled pigmentation.

Authors:  Yuji Horiguchi; Daisuke Sawamura; Ryoko Mori; Hideki Nakamura; Kenzo Takahashi; Hiroshi Shimizu
Journal:  J Invest Dermatol       Date:  2005-07       Impact factor: 8.551

Review 5.  The quest for the mechanism of melanin transfer.

Authors:  Karolien Van Den Bossche; Jean-Marie Naeyaert; Jo Lambert
Journal:  Traffic       Date:  2006-07       Impact factor: 6.215

6.  Complete amino acid sequence of a mouse epidermal keratin subunit and implications for the structure of intermediate filaments.

Authors:  P M Steinert; R H Rice; D R Roop; B L Trus; A C Steven
Journal:  Nature       Date:  1983-04-28       Impact factor: 49.962

7.  Transgenic mice expressing a mutant keratin 10 gene reveal the likely genetic basis for epidermolytic hyperkeratosis.

Authors:  E Fuchs; R A Esteves; P A Coulombe
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

8.  Molecular consequences of deletion of the cytoplasmic domain of bullous pemphigoid 180 in a patient with predominant features of epidermolysis bullosa simplex.

Authors:  Lionel Fontao; Kaisa Tasanen; Marcel Huber; Daniel Hohl; Jan Koster; Leena Bruckner-Tuderman; Arnoud Sonnenberg; Luca Borradori
Journal:  J Invest Dermatol       Date:  2004-01       Impact factor: 8.551

9.  The coiled coil of in vitro assembled keratin filaments is a heterodimer of type I and II keratins: use of site-specific mutagenesis and recombinant protein expression.

Authors:  M Hatzfeld; K Weber
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

10.  The roles of K5 and K14 head, tail, and R/K L L E G E domains in keratin filament assembly in vitro.

Authors:  A K Wilson; P A Coulombe; E Fuchs
Journal:  J Cell Biol       Date:  1992-10       Impact factor: 10.539

View more
  72 in total

1.  Modeling the self-organization property of keratin intermediate filaments.

Authors:  Jin Seob Kim; Chang-Hun Lee; Pierre A Coulombe
Journal:  Biophys J       Date:  2010-11-03       Impact factor: 4.033

Review 2.  "IF-pathies": a broad spectrum of intermediate filament-associated diseases.

Authors:  M Bishr Omary
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

3.  [Epidermolysis bullosa : Diagnosis and therapy].

Authors:  C Has; L Bruckner-Tuderman
Journal:  Hautarzt       Date:  2011-02       Impact factor: 0.751

4.  "Panta rhei": Perpetual cycling of the keratin cytoskeleton.

Authors:  Rudolf E Leube; Marcin Moch; Anne Kölsch; Reinhard Windoffer
Journal:  Bioarchitecture       Date:  2011-01

5.  Mathematical modeling of the impact of actin and keratin filaments on keratinocyte cell spreading.

Authors:  Jin Seob Kim; Chang-Hun Lee; Baogen Y Su; Pierre A Coulombe
Journal:  Biophys J       Date:  2012-11-07       Impact factor: 4.033

6.  Unique amino acid signatures that are evolutionarily conserved distinguish simple-type, epidermal and hair keratins.

Authors:  Pavel Strnad; Valentyn Usachov; Cedric Debes; Frauke Gräter; David A D Parry; M Bishr Omary
Journal:  J Cell Sci       Date:  2012-01-03       Impact factor: 5.285

Review 7.  The role of keratins in the digestive system: lessons from transgenic mouse models.

Authors:  Hayan Yi; Han-Na Yoon; Sujin Kim; Nam-On Ku
Journal:  Histochem Cell Biol       Date:  2018-07-24       Impact factor: 4.304

Review 8.  Post-translational modifications of intermediate filament proteins: mechanisms and functions.

Authors:  Natasha T Snider; M Bishr Omary
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

9.  Mutation of caspase-digestion sites in keratin 18 interferes with filament reorganization, and predisposes to hepatocyte necrosis and loss of membrane integrity.

Authors:  Sujith V W Weerasinghe; Nam-On Ku; Peter J Altshuler; Raymond Kwan; M Bishr Omary
Journal:  J Cell Sci       Date:  2014-01-24       Impact factor: 5.285

10.  Differential modulation of keratin expression by sulforaphane occurs via Nrf2-dependent and -independent pathways in skin epithelia.

Authors:  Michelle Kerns; Daryle DePianto; Masayuki Yamamoto; Pierre A Coulombe
Journal:  Mol Biol Cell       Date:  2010-10-06       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.